National Health Investors, Inc. (NYSE:NHI) Short Interest Down 44.0% in July

National Health Investors, Inc. (NYSE:NHI) was the recipient of a large decline in short interest during the month of July. As of July 15th, there was short interest totaling 2,094,689 shares, a decline of 44.0% from the June 30th total of 3,740,952 shares. Based on an average daily volume of 441,598 shares, the short-interest ratio is currently 4.7 days. Approximately 4.4% of the company’s shares are short sold.

Insider Buying and Selling at National Health Investors

In other National Health Investors news, Director Robert A. Mccabe, Jr. acquired 890 shares of National Health Investors stock in a transaction on Monday, June 15th. The shares were purchased at an average cost of $71.65 per share, with a total value of $63,768.50. Following the completion of the purchase, the director owned 44,159 shares in the company, valued at $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of National Health Investors stock in a transaction dated Friday, June 5th. The stock was bought at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares in the company, valued at $9,177,473.44. The trade was a 1.14% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On National Health Investors

Hedge funds have recently added to or reduced their stakes in the business. Moody National Bank Trust Division bought a new position in shares of National Health Investors in the second quarter valued at about $723,000. Pensionfund PDN boosted its holdings in shares of National Health Investors by 74.3% during the 2nd quarter. Pensionfund PDN now owns 12,200 shares of the real estate investment trust’s stock worth $930,000 after buying an additional 5,200 shares during the period. Pensionfund Sabic grew its stake in National Health Investors by 71.4% in the 2nd quarter. Pensionfund Sabic now owns 6,000 shares of the real estate investment trust’s stock valued at $458,000 after buying an additional 2,500 shares during the last quarter. Militia Capital Management LLC acquired a new position in National Health Investors in the 1st quarter valued at about $2,458,000. Finally, NewEdge Advisors LLC raised its holdings in National Health Investors by 18.1% in the 1st quarter. NewEdge Advisors LLC now owns 12,046 shares of the real estate investment trust’s stock valued at $974,000 after acquiring an additional 1,844 shares during the period. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Stock Down 0.5%

NHI traded down $0.36 on Wednesday, hitting $78.18. 253,165 shares of the company were exchanged, compared to its average volume of 440,377. National Health Investors has a 12 month low of $67.94 and a 12 month high of $91.38. The company has a market cap of $3.79 billion, a PE ratio of 25.22, a PEG ratio of 3.56 and a beta of 0.51. The company has a debt-to-equity ratio of 0.83, a quick ratio of 8.20 and a current ratio of 8.20. The stock’s fifty day moving average is $75.13 and its 200-day moving average is $79.77.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be paid a $0.92 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $3.68 annualized dividend and a yield of 4.7%. National Health Investors’s dividend payout ratio is currently 118.71%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. Truist Financial cut their price objective on National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a report on Friday, June 12th. Wells Fargo & Company lowered their target price on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research note on Monday, June 1st. BMO Capital Markets dropped their target price on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a report on Monday, June 15th. Zacks Research lowered shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a report on Thursday, June 25th. Five research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $83.86.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.